The binding of 3H-labelled [8-arginine]vasopressin to human platelets or crude platelet membranes was examined. Both preparations specifically bound [8-arginine]vasopressin. The binding increased linearly with protein concentration, it was temperature-and time-dependent, saturable and could be reversed to a large extent by EDTA (10 mM). In this latter case, addition of an excess of MgCl2 (20 mM) restored the initial level of binding. Intact platelets and membranes derived from these platelets presented a single population ofbinding sites with a dissociation constant (Kd) of 1.3 + 0.2 and 1.8 + 0.3 nm and a maximal binding capacity of 142 + 48 and 270+ 17 fmol/mg of protein, respectively. The Kd values of various analogues correlated well with those determined on rat liver membrane V1 vasopressin receptors but not with those determined on rat kidney membrane V2 receptors.
INTRODUCTION
Vasopressin exerts a large variety of biological effects in mammals and in particular has antidiuretic properties, contracts the arteries and acts as a glycogenolytic agent on the liver (for review see De Wulf et al., 1980) . In addition to many other biological effects (Jard, 1983) , vasopressin has been shown to cause the aggregation of human blood platelets (Haslam & Rosson, 1972) .
Vasopressin does not exert all its biological activities with cyclic AMP as second messenger. On the basis of both functional and pharmacological criteria, two types of vasopressin receptors can be distinguished (Michell et al., 1979) : V2 renal receptors, leading to the activation of adenylate cyclase (Bockaert et al., 1973) , and V1 receptors, which mediate pressor and glycogenolytic actions of vasopressin, acting by a rise in the concentration of intracellular calcium (Keppens et al., 1977) . Vasopressin also causes enhancement of polyphosphoinositide breakdown in hepatocytes (Kirk et al., 1980) , and it has been suggested that this may represent an early step in the calcium-mobilizing effect of vasopressin.
Previous studies suggest that the platelet vasopressin receptor is of the V1 subtype, since platelet aggregation induced by vasopressin is potently inhibited by [1-(fimercapto-fl6J'-cyclopentamethylenepropionic acid), 8-arginine]vasopressin (Thomas et al., 1983) or des-1-amino- [4-vaiine,8-D-arginine] vasopressin (Vanderwell et al., 1983) , which are V1 antagonists, whereas des-l-amino- [8-D-arginine] vasopressin, a selective V2 agonist, fails to induce aggregation of human platelets (Thomas et al., 1983) . On the other hand, Berrettini et al. (1982) Preparation of washed human platelets. Citrated platelet-rich plasma (40 ml) was centrifuged firstly at 200 g for 10 min at 18°C, to remove contaminating red cells, and secondly at 2450 g for 15 min at 4°C, to pellet the platelets. The platelet plug was washed three times at 4°C by resuspension and centrifugation in an iso-osmotic buffer solution (NaCl, 100 mM; EDTA, 5 mm; MgCl2, 15 mM; Tris/HCl, pH 7.4, 50 mM). The washed platelets were finally resuspended in 10-20 ml of the same buffer.
Preparation of partially purified platelet membranes. Human platelets were isolated and washed as above; they Tris/HCI, pH 7.4, 10 mM). After freezing and thawing three times ofthis suspension, the particulate fraction was isolated by centrifugation at 30000 g for 15 min at 4 'C. This centrifugation step was repeated twice and the membrane pellet was finally resuspended in 3-5 ml of the washing iso-osmotic buffer. The preparation was either used immediately or stored in liquid N2 for 1 week.
13HiAVP binding assays
All experiments were done in triplicate. Protein concentration was measured (Lowry et al., 1951) from an aliquot of washed platelets or platelet membranes.
Measurement of 13HiAVP binding to intact platelets.
The incubation medium (final volume 200 ,ul) contained: iso-osmotic buffer (NaCl, 100 mM; EDTA, 5 mM; MgCl2, 15 mM; Tris/HCl, pH 7.4,50 mM), bovine serum albumir (2 mg/ml), bacitracin (1 mg/ml), and various amounts of [3H]AVP (except when otherwise stated). The reaction was initiated by the addition of 100 pl of platelet suspension (2 x 108 cells). Incubation was carried out at 30 'C with gentle shaking; it was stopped by the addition of cold iso-osmotic solution (NaCl, 150 mM; MgCl2, 10 mM; Tris/HCl, pH 7.4, 50 mM), and the content of the tubes was immediately filtered through Whatman GF/C filters presoaked with 4 ml of the same buffer. Filters were washed four times with 4 ml of the stopping solution. Radioactivity of filters was measured by liquid-scintillation counting. Non-specific binding was determined in 
RESULTS
[3H]AVP specific binding to intact platelets or platelet membranes was linear with the amount of protein (0-400 and 0-100 jug of protein/assay) for platelets and platelet membranes respectively (results not shown); it was temperature-and time-dependent (Fig. 1) The relative affinities of a series of vasopressin analogues for the [3H]AVP binding sites in human platelets, determined from competition experiments, reveal a high degree of specificity (for details see Table  1 ). The Kd values determined correlate rather well with those found in rat liver membranes, but no correlation appears with those observed in rat kidney membranes. These results, using nine vasopressin analogues, support previous partial pharmacological results (Thomas et al., 1983; Vanderwell et al., 1983) . Although we had compared affinities of vasopressin analogues which correspond to different species (rat and human), they suggest that the platelet vasopressin receptor is of the V1 subtype, according to the classification of Michell et al. (1979) , and corroborate the lack of stimulation Gfplatelet 1986 membrane adenylate cyclase activity by AVP (Haslam et al., 1978) . Elsewhere, previous studies on the relationship between the primary signal in vasopressin action and the final biological response had indicated that this was so: Drummond et al. (1985) (Haslam & Rosson, 1972) . Thus only a small fraction of platelet vasopressin receptors may be activated in normal conditions, and only unusually high concentrations of blood AVP, such as those observed in haemorrhage (Arnoud et al., 1977) or water deprivation (Landgraf & Gunther, 1983) 
